As the field of onco-hematology is constantly, often turbulently, evolving, the promotion of meetings that allow researchers to compare and share information, transferring acquisitions obtained from the study of the genome to the bedside, is crucial and can lead to the development of innovative personalized treatments with highest therapeutic effect and lowest toxicity burden. In this context, we believe that a discussion on the state of the art of blood and lymphatic tissue cancers could represent an important scientific, cultural and informative contribution of the national and international medical community, in the year in which the World Health Organization is preparing to publish guidelines for the – increasingly molecular – diagnosis and treatment of such conditions.
Registration deadline: February 12, 2016 The number of participants is limited to 120
For further information and registration: www.hematologysymposium2016.eu, hematology2016@ieo.eu
SCIENTIFIC COMMITTEE
Francesco Bertolini,
European Institute of Oncology, Milan, Italy
Riccardo Dalla Favera,
Columbia University, New York, New York, USA
Francesco Lo Coco,
Università Tor Vergata, Rome, Italy
Pier Giuseppe Pelicci,
European Institute of Oncology, Milan, Italy
Stefano A. Pileri,
European Institute of Oncology, Milan, Italy
Corrado Tarella,
European Institute of Oncology, Milan, Italy
KEYNOTE LECTURERS
Michael Stratton,
Wellcome Trust Sanger Institute, Hinxton, UK
Stefano A. Pileri,
European Institute of Oncology, Milan, Italy
Felice Bombaci,
Patient Advocate, Gruppo AIL Pazienti Leucemia Mieloide Cronica, Rome, Italy
